Concentric Analgesics Announces Completion of $20 Million Financing and Appoints Two New Board Members as it Prepares to Initiate Registration-Enabling Phase 3 Studies for Vocacapsaicin

vocacapsaicin (CA-008) - Concentric Analgesics

Jan 26, 2022